glp-1 alzheimer's study Frontiers Can popular diabetes and weight-loss
Description
Exp Mol Med 2022;54:37792
DOI:10.31579/2835-8325/196 Copyright: 2026, Rehan Haider
These results suggest that IF ameliorates glucocorticoid-induced bone loss primarily by suppressing osteoclastogenesis and PTH secretion and promoting osteoblastic activity
FDA approval is anticipated in late 2026
A friendly reminder that while calorie restriction can achieve short-term reductions in weight ( 12 months)
